Alpine Immune Sciences Stock Price. Everything You Need To Know About The Alpine Immune Sciences Stock!
Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company, which engages in the discovery of protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. The company is headquartered in Seattle, Washington and currently employs 126 full-time employees. The company went IPO on 2015-06-17. The firm is focused on discovering and developing protein-based immunotherapies to treat autoimmune and inflammatory diseases. The firm’s scientific platform uses a directed evolution process to convert native immune system proteins from the immunoglobulin super family (IgSF) into multi-targeted therapeutics capable of modulating the human immune system. The Company’s product candidates include ALPN-101, ALPN-202 and ALPN-303. ALPN-101 is a dual inducible T cell costimulator (ICOS) and cluster of differentiation 28 (CD28) antagonist intended for the treatment of autoimmune and inflammatory diseases. Its oncology program is ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor intended for the treatment of cancer. ALPN-303 is a dual B-cell cytokine antagonist for the treatment of B-cell mediated diseases.
Alpine Immune Sciences Stock Price. Everything You Need To Know About The Alpine Immune Sciences Stock! performance
- Employees 126
- Company HQ Seattle
- Website https://www.alpineimmunesciences.com/
- ALPN Asset Type Common Stock
- ALPN Market Capitalization 4.2B
- Earnings Per Share -0.64
- Dividends Per Share None
- Dividend Date 2017-07-25
- Quarterly Earnings Growth 0
Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking for an opportunity to invest in the stock market? Look no further than Alpine Immune Sciences. As an content marketing expert at Zorion, an investment platform committed to helping retail investors make informed decisions, I can guide you on how to invest in this promising stock. Alpine Immune Sciences is a cutting-edge biotechnology company revolutionizing the field of immunotherapy. With its innovative platform, the company is developing transformative medicines to treat cancer, autoimmune, and inflammatory diseases. To invest in Alpine Immune Sciences from Malaysia, Thailand, Indonesia, or Vietnam, follow these simple steps. Firstly, open an account with Zorion, our investment platform that offers real US stocks and Pre-IPO companies to investors like you. Next, conduct thorough research on the stock and understand its business model, competitive advantage, and growth potential. After analyzing the stock’s prospects, make an investment decision based on your risk appetite and financial goals. Zorion’s investment insights and recommendations can provide valuable guidance during this process. Once you have made your decision, execute the trade through Zorion’s user-friendly platform. Remember that investing in the stock market involves risks, and it’s crucial to diversify your portfolio for optimal returns. Zorion provides resources and educational materials to enhance your investment knowledge and help you make well-informed choices. Investing in Alpine Immune Sciences from Malaysia, Thailand, Indonesia, or Vietnam is an opportunity to be part of the biotech revolution. With Zorion’s expertise and resources, you can confidently navigate the stock market and make the most of this enticing investment opportunity. Start your investing journey with Alpine Immune Sciences and Zorion today.
